| 1. |
Liang CA, Jambusaria-Pahlajani A, Karia PS, et al. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. J Am Acad Dermatol, 2014, 71(4):781-786.
|
| 2. |
Al Tarakji M, Toro A, Di Carlo I, et al. Unusual presentation of dermatofibrosarcoma protuberans in a male patient's breast:a case report and review of the literature. World J Surg Oncol, 2015, 13:158.
|
| 3. |
Llombart B, Serra-Guillén C, Monteagudo C, et al. Dermatofibrosar-coma protuberans:a comprehensive review and update on diagnosis and management. Semin Diagn Pathol, 2013, 30(1):13-28.
|
| 4. |
Edelweiss M, Malpica A. Dermatofibrosarcoma protuberans of the vulva:a clinicopathologic and immunohistochemical study of 13 cases. Am J Surg Pathol, 2010, 34(3):393-400.
|
| 5. |
罗振东, 陈卫国, 郑彤, 等. MRI 诊断隆凸性皮肤纤维肉瘤. 中国医学影像技术, 2011, 27(8):1672-1675.
|
| 6. |
Walluks K, Chen Y, Woelfel C, et al. Molecular and clinicopatho-logical analysis of dermatofibrosarcoma protuberans. Pathol Res Pract, 2013, 209(1):30-35.
|
| 7. |
West RB, Harvell J, Linn SC, et al. Apo D in soft tissue tumors:a novel marker for dermatofibrosarcoma protuberans. Am J Surg Pathol, 2004, 28(8):1063-1069.
|
| 8. |
Rutkowski P, Debiec-Rychter M. Current treatment options for dermatofibrosarcoma protuberans. Expert Rev Anticancer Ther, 2015, 15(8):901-909.
|
| 9. |
Valdivielso-Ramos M, Hernanz JM. Dermatofibrosarcoma protu-berans in childhood. Actas Dermosifiliogr, 2012, 103(10):863-873.
|
| 10. |
Otani S, Ishii H, Hashinaga K, et al. Pulmonary metastasis of fibro-sarcomatous variant of dermatofibrosarcoma protuberans:case report and review of literature. Nihon Kokyuki Gakkai Zasshi, 2008, 46(3):253-257.
|
| 11. |
Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet, 2003, 140(1):1-12.
|
| 12. |
Loghdey MS, Varma S, Rajpara SM, et al. Mohs micrographic surgery for dermatofibrosarcoma protuberans (DFSP):a single-centre series of 76 patients treated by frozen-section Mohs micrographic surgery with a review of the literature. J Plast Reconstr Aesthet Surg, 2014, 67(10):1315-1321.
|
| 13. |
Ballo MT, Zagars GK, Pisters P, et al. The role of radiation therapy in the management of dermatofibrosarcoma protuberans. Int J Radiat Oncol Biol Phys, 1998, 40(4):823-827.
|
| 14. |
Bichakjian CK, Olencki T, Alam M, et al. Dermatofibrosarcoma protuberans, version 1. 2014. J Natl Compr Canc Netw, 2014, 12(6):863-868.
|
| 15. |
Labropoulos SV, Fletcher JA, Oliveira AM, et al. Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs, 2005, 16(4):461-466.
|
| 16. |
McArthur GA, Demetri GD, van Oosterom A, et al. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib:Imatinib Target Exploration Consortium Study B2225. J Clin Oncol, 2005, 23(4):866-873.
|
| 17. |
Heinrich MC, Joensuu H, Demetri GD, et al; Imatinib Target Explo-ration Consortium Study B2225. Phase Ⅱ, open-label study evalua ting the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases. Clin Cancer Res, 2008, 14(9):2717-2725.
|
| 18. |
Kérob D, Porcher R, Vérola O, et al. Imatinib mesylate as a preoper-ative therapy in dermatofibrosarcoma:results of a multicenter phase Ⅱ study on 25 patients. Clin Cancer Res, 2010, 16(12):3288-3295.
|
| 19. |
Ugurel S, Mentzel T, Utikal J, et al. Neoadjuvant imatinib in adva-nced primary or locally recurrent dermatofibrosarcoma protuberans:a multicenter phase Ⅱ DeCOG trial with long-term follow-up. Clin Cancer Res, 2014, 20(2):499-510.
|
1/5
WeChat